In acute myocardial infarction, which medication is used as an anticoagulant in the acute phase?

In acute myocardial infarction, which medication is used as an anticoagulant in the acute phase?

• A. Beta blockers
• B. ACE inhibitors
• C. Statins
• D. Low-molecular-weight heparin

Answer: (D)

In the acute phase of a myocardial infarction, the goal is to prevent further thrombus formation and propagation while reperfusion therapies are organized. Anticoagulants help by inhibiting the coagulation cascade, reducing the risk of new clot growth. Low-molecular-weight heparin is favored here because it provides reliable anticoagulation with subcutaneous dosing, has predictable effects that don’t require constant monitoring like unfractionated heparin, and has been shown to reduce events in acute coronary settings. It mainly inhibits factor Xa via antithrombin III, with some activity against thrombin, helping to limit new fibrin formation during this critical period. The other drugs listed are not anticoagulants; beta blockers, ACE inhibitors, and statins treat other aspects of myocardial infarction care—reducing heart workload, preventing remodeling, and lowering lipids, respectively—rather than directly preventing clot extension in the acute phase.

In the acute phase of a myocardial infarction, the goal is to prevent further thrombus formation and propagation while reperfusion therapies are organized. Anticoagulants help by inhibiting the coagulation cascade, reducing the risk of new clot growth. Low-molecular-weight heparin is favored here because it provides reliable anticoagulation with subcutaneous dosing, has predictable effects that don’t require constant monitoring like unfractionated heparin, and has been shown to reduce events in acute coronary settings. It mainly inhibits factor Xa via antithrombin III, with some activity against thrombin, helping to limit new fibrin formation during this critical period.

The other drugs listed are not anticoagulants; beta blockers, ACE inhibitors, and statins treat other aspects of myocardial infarction care—reducing heart workload, preventing remodeling, and lowering lipids, respectively—rather than directly preventing clot extension in the acute phase.